ERNA logo

Eterna Therapeutics (ERNA) Free Cash Flow

ERNA Annual FCF

-$20.43 M
+$846.00 K+3.98%

31 December 2023

ERNA Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ERNA Quarterly FCF

-$6.30 M
-$3.80 M-151.36%

30 September 2024

ERNA Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ERNA TTM FCF

-$17.32 M
-$478.00 K-2.84%

30 September 2024

ERNA TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ERNA Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.0%-35.3%+15.1%
3 y3 years-150.9%-4.2%+20.7%
5 y5 years-150.9%-4.2%+20.7%

ERNA Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+13.6%-151.4%+9.7%-2.8%+32.6%
5 y5-year-150.9%+13.6%-281.9%+9.7%-822.5%+32.6%
alltimeall time-150.9%+13.6%-281.9%+9.7%-822.5%+32.6%

Eterna Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$6.30 M(+151.4%)
-$17.32 M(+2.8%)
June 2024
-
-$2.51 M(-34.8%)
-$16.84 M(-7.5%)
Mar 2024
-
-$3.85 M(-17.4%)
-$18.21 M(-10.8%)
Dec 2023
-$20.43 M(-4.0%)
-$4.66 M(-20.0%)
-$20.41 M(-3.7%)
Sept 2023
-
-$5.83 M(+50.5%)
-$21.20 M(-1.5%)
June 2023
-
-$3.87 M(-36.0%)
-$21.54 M(-1.4%)
Mar 2023
-
-$6.05 M(+10.9%)
-$21.84 M(+2.7%)
Dec 2022
-$21.27 M
-$5.46 M(-11.4%)
-$21.27 M(-6.7%)
Sept 2022
-
-$6.16 M(+47.3%)
-$22.80 M(-1.2%)
June 2022
-
-$4.18 M(-23.7%)
-$23.07 M(-10.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$5.48 M(-21.5%)
-$25.69 M(+8.7%)
Dec 2021
-$23.64 M(+190.4%)
-
-
Dec 2021
-
-$6.98 M(+8.6%)
-$23.64 M(+29.1%)
Sept 2021
-
-$6.43 M(-5.5%)
-$18.31 M(+28.1%)
June 2021
-
-$6.80 M(+98.4%)
-$14.29 M(+47.4%)
Mar 2021
-
-$3.43 M(+107.8%)
-$9.69 M(+19.1%)
Dec 2020
-$8.14 M
-$1.65 M(-31.4%)
-$8.14 M(+25.4%)
Sept 2020
-
-$2.41 M(+9.1%)
-$6.49 M(+58.9%)
June 2020
-
-$2.21 M(+17.4%)
-$4.08 M(+117.4%)
Mar 2020
-
-$1.88 M
-$1.88 M

FAQ

  • What is Eterna Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Eterna Therapeutics?
  • What is Eterna Therapeutics annual FCF year-on-year change?
  • What is Eterna Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Eterna Therapeutics?
  • What is Eterna Therapeutics quarterly FCF year-on-year change?
  • What is Eterna Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Eterna Therapeutics?
  • What is Eterna Therapeutics TTM FCF year-on-year change?

What is Eterna Therapeutics annual free cash flow?

The current annual FCF of ERNA is -$20.43 M

What is the all time high annual FCF for Eterna Therapeutics?

Eterna Therapeutics all-time high annual free cash flow is -$8.14 M

What is Eterna Therapeutics annual FCF year-on-year change?

Over the past year, ERNA annual free cash flow has changed by +$846.00 K (+3.98%)

What is Eterna Therapeutics quarterly free cash flow?

The current quarterly FCF of ERNA is -$6.30 M

What is the all time high quarterly FCF for Eterna Therapeutics?

Eterna Therapeutics all-time high quarterly free cash flow is -$1.65 M

What is Eterna Therapeutics quarterly FCF year-on-year change?

Over the past year, ERNA quarterly free cash flow has changed by -$1.64 M (-35.25%)

What is Eterna Therapeutics TTM free cash flow?

The current TTM FCF of ERNA is -$17.32 M

What is the all time high TTM FCF for Eterna Therapeutics?

Eterna Therapeutics all-time high TTM free cash flow is -$1.88 M

What is Eterna Therapeutics TTM FCF year-on-year change?

Over the past year, ERNA TTM free cash flow has changed by +$3.09 M (+15.13%)